Spinal Muscular Atrophy Drug Development Announced
Families of SMA announced recently the selection of a clinical candidate for spinal muscular atrophy through its program being conducted at deCODE chemistry. The lead compounds have shown the ability to extend survival in a mouse model of SMA.
For more information on this announcement, you can read the news release from FSMA.
research, sma, spinal muscular atrophy, treatmentShare This Post Via Email or Social Bookmark
